Clinical Trial Update: Efficacy and Safety of Talsaclidine (Free Base) in Patients With Mild to Moderate Dementia of Alzheimer Type [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the efficacy and safety of talsaclidine (free base) in patients with mild-to-moderate Alzheimer's disease. The study status is t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Talsaclidine (Free Base) (talsaclidine)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Alzheimer Disease | Phase 2 | Status: TERMINATED